newsfilter
← Latest News
GlobeNewswire·

Abivax Provides 2026 Corporate Outlook

Abivax Provides 2026 Corporate Outlook New market insights indicate significant future expansion of the ulcerative colitis (UC) market, with obefazimod well positioned to become a future market leader in the IBD